TBTC NAA Study: Pilot Study of Surrogate Markers for Outcome of TB Treatment
NCT00023439 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2011-08-03
Summary
This is a pilot study to evaluate the performance of several nucleic acid amplification methodologies in the diagnosis and management of active tuberculosis
Conditions
Interventions
- OTHER
-
Nucleic Acid Amplification Methods for diagnosis
no intervention
Sponsors & Collaborators
-
US Department of Veterans Affairs
collaborator FED -
Centers for Disease Control and Prevention
lead FED
Principal Investigators
-
Marc Weiner, MD · Audie L. Murphy VA Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-05-31
Countries
- United States
- Canada
- South Africa
- Uganda
Study Locations
More Related Trials
-
Prospective Comparison of the Tuberculin Skin Test and Interferon-Gamma Release Assays in Diagnosing Infection With Mycobacterium Tuberculosis and in Predicting Progression to Tuberculosis
NCT01622140 ·Status: COMPLETED
-
Using Biomarkers to Predict TB Treatment Duration
NCT02821832 ·Status: COMPLETED ·Phase: PHASE2
-
Host Blood RNA Signatures for Diagnosis of TB
NCT05542511 ·Status: ACTIVE_NOT_RECRUITING
-
TBTC Study 25: Study of the Tolerability of Higher Doses of Rifapentine in the Treatment of Tuberculosis
NCT00023426 ·Status: COMPLETED ·Phase: PHASE2
-
Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis in Patients With HIV?
NCT00763295 ·Status: COMPLETED
-
Microneedles for Diagnosis of LTBI
NCT04552015 ·Status: TERMINATED ·Phase: NA
-
Sputum-free Diagnostis of TB
NCT07125274 ·Status: RECRUITING
-
Post-Trial Tuberculosis Case Finding: A Substudy of CoVPN 3008
NCT06585683 ·Status: COMPLETED
-
TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis
NCT00023335 ·Status: COMPLETED ·Phase: PHASE3
-
Tuberculosis Prevention for HIV Infected Adults
NCT00057122 ·Status: COMPLETED ·Phase: PHASE3
-
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
NCT00694629 ·Status: COMPLETED ·Phase: PHASE2
-
Characterization and Evaluation of Diagnostic Biomarkers for Tuberculosis
NCT01269268 ·Status: COMPLETED
-
Shortened Regimens for Drug-susceptible Pulmonary Tuberculosis
NCT02901288 ·Status: UNKNOWN ·Phase: PHASE4
-
Gene Xpert Diagnosis of TB Using Tracheal Aspirates From Intensive Care Unit (ICU) Patients
NCT01530568 ·Status: COMPLETED ·Phase: NA
-
Rapid Research in Diagnostics Development for TB Network
NCT04923958 ·Status: RECRUITING ·Phase: NA
-
Training Protocol on the Natural History of Tuberculosis
NCT01212003 ·Status: RECRUITING
-
RIPE vs RIPE Plus N-acetylcysteine in Patients With HIV/TB Co-infection
NCT03281226 ·Status: UNKNOWN ·Phase: PHASE2
-
Faster Identification of TB and Evaluation of Drug Resistance in HIV-infected People
NCT00959088 ·Status: COMPLETED
-
Evaluation of Immune Cell Markers in Diagnosis of Tuberculosis
NCT04148053 ·Status: UNKNOWN
-
Integrated Discovery and Development of Innovative TB Diagnostics
NCT06624501 ·Status: COMPLETED
-
Evaluation of the Practice of Three Morning Sputa on Separate Days for Diagnosis of Mtb
NCT00212550 ·Status: COMPLETED
-
NexGen EBA Radiologic and Immunologic Biomarkers of Sterilizing Drug Activity in Tuberculosis
NCT02371681 ·Status: COMPLETED ·Phase: PHASE2
-
A Multiple Ascending Dose Study With a Dose Formulation Comparison Cohort to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBA-354 in Healthy Adult Subjects
NCT02606214 ·Status: TERMINATED ·Phase: PHASE1
-
TBTC Study 24: Intermittent Treatment of TB With Isoniazid Resistance or Intolerance
NCT00023374 ·Status: COMPLETED ·Phase: NA
-
Three Months of Weekly Rifapentine and Isoniazid for M. Tuberculosis Infection
NCT00023452 ·Status: COMPLETED ·Phase: PHASE3